Orgenesis Inc (ORGS)

Currency in USD
0.004
+0.003(+300.00%)
Closed·
ORGS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0040.004
52 wk Range
0.0011.080
Key Statistics
Prev. Close
0.001
Open
0.004
Day's Range
0.004-0.004
52 wk Range
0.001-1.08
Volume
1.01K
Average Volume (3m)
1.33K
1-Year Change
-99.5962%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ORGS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Orgenesis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
13-11-2024
EPS / Forecast
-1.93 / 0.17
Revenue / Forecast
347K / 18.5M
EPS Revisions
Last 90 days

ORGS Income Statement

Compare ORGS to Peers and Sector

Metrics to compare
ORGS
Peers
Sector
Relationship
P/E Ratio
0.0x−6.3x−0.4x
PEG Ratio
0.00−0.250.00
Price/Book
0.0x2.7x2.6x
Price / LTM Sales
0.0x7.5x3.0x
Upside (Analyst Target)
0.0%83.6%53.5%
Fair Value Upside
Unlock−0.1%9.0%Unlock

Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
4.64M47.32%19.47K
Public Companies & Retail Investors
5.16M52.68%21.68K
Total
9.8M100.00%41.16K

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Alpha Prosperity Fund SPC - Segregated Portfolio Fund46.80%45,86,05119
Knoll Capital Management0.52%50,6230

FAQ

What Is the Orgenesis (ORGS) Share Price Today?

The Orgenesis share price today is 0.004.

What is the current Orgenesis (ORGS) share price and day range?

As of 19-07-2026, the Orgenesis share price is 0.004, with a previous close of 0.001. The share price has ranged from 0.004 to 0.004 today, while the 52-week range spans from 0.001 to 1.080.

What Is the Orgenesis Market Cap?

As of today, Orgenesis market cap is 41.160K.

What Is Orgenesis's Earnings Per Share (TTM)?

The Orgenesis EPS (TTM) is -11.438.

From a Technical Analysis Perspective, Is ORGS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Orgenesis Trade On?

Orgenesis is listed and trades on the OTC Markets.

What Is the Stock Symbol for Orgenesis?

The stock symbol for Orgenesis is "ORGS."

How Many Times Has Orgenesis Stock Split?

Orgenesis has split 3 times.

How Many Employees Does Orgenesis Have?

Orgenesis has 77 employees.

What Is the ORGS After Hours Price?

ORGS's last after hours stock price is 1.850, the stock has changed by -0.030, or -1.600%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.